Absolute Investment Advisers LLC increased its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 112.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 582,256 shares of the company’s stock after acquiring an additional 308,562 shares during the quarter. Absolute Investment Advisers LLC’s holdings in BlackRock Health Sciences Term Trust were worth $8,676,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of the business. Allspring Global Investments Holdings LLC increased its position in BlackRock Health Sciences Term Trust by 2.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 302,049 shares of the company’s stock worth $4,501,000 after buying an additional 6,458 shares during the last quarter. Brown Lisle Cummings Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 3.6% during the 1st quarter. Brown Lisle Cummings Inc. now owns 44,260 shares of the company’s stock worth $659,000 after acquiring an additional 1,549 shares during the period. Cambridge Investment Research Advisors Inc. increased its holdings in BlackRock Health Sciences Term Trust by 6.1% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 64,090 shares of the company’s stock worth $955,000 after acquiring an additional 3,698 shares during the last quarter. Janney Montgomery Scott LLC increased its holdings in BlackRock Health Sciences Term Trust by 9.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 30,163 shares of the company’s stock worth $449,000 after acquiring an additional 2,668 shares during the last quarter. Finally, NewGen Asset Management Ltd bought a new stake in BlackRock Health Sciences Term Trust in the 1st quarter valued at about $1,283,000.
BlackRock Health Sciences Term Trust Trading Down 0.1%
Shares of NYSE:BMEZ opened at $14.46 on Friday. The company has a 50-day moving average price of $14.43 and a two-hundred day moving average price of $14.90. BlackRock Health Sciences Term Trust has a twelve month low of $12.58 and a twelve month high of $16.75.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Read More
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Stock Market Sectors: What Are They and How Many Are There?
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- The Role Economic Reports Play in a Successful Investment Strategy
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.